<DOC>
	<DOC>NCT00625547</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of cabergoline compared with levodopa in the treatment of patients with RLS.</brief_summary>
	<brief_title>A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Diagnosis of idiopathic RLS and had all 4 clinical manifestations of RLS Moderate to severe symptoms of RLS as indicated by an IRLSSGRS total score greater than or equal to 10 and a severity at night score of greater than or equal to 4 on an 11point RLS6 rating scale No previous treatment for RLS or dissatisfaction with their current therapy Not available</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>